Researchers have successfully used human induced pluripotent stem cells (iPSCs) to treat rodents afflicted with Parkinson’s disease. The research, which validates a scalable protocol that the same group had previously developed, can be used to manufacture the type of neurons needed to treat the disease and paves the way for the use of iPSC’s in… [Continue Reading]
According to researchers, adult cells that have been reprogrammed into induced pluripotent stem cells (iPS cells) do not completely let go of their past, perhaps limiting their ability to function as a less controversial alternative to embryonic stem cells for basic research and cell replacement therapies. The findings highlight a major challenge in developing clinical… [Continue Reading]
Researchers are applying new stem cell technology to use skin samples to grow the brain cells thought to be responsible for the onset of Parkinson’s disease. Dr Richard Wade-Martins and his team will be gathering data from over 1,000 patients with early stage Parkinson’s disease and taking small samples of skin tissue to grow special… [Continue Reading]
Scientists may be one step closer to being able to generate any type of cells and tissues from a patient’s own cells. Investigators describe finding that an important cluster of genes is inactivated in induced pluripotent stem cells that do not have the full development potential of embryonic stem cells.